RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Normalized Earnings Analysis of CRH MedicalYou answered your question yourself. The market views the company priorites as growth and using capital to broaden the market base, increase acquisitions in order to raise volume and offset lower reimbursement rates, and have the sp going up by profit margin and not buy-backs. And that is what is meant buy-backs from a position of strength. For what would be the point to buy back stock now, raise the sp to, say to $4, and the stock stagnate at this level? We need volume and increased profit margins in order for the co to grow. After all, there is a limit to credit facility and unless the company makes money it won't be able to borrow and acquire new companies indefinitely, as Fitzerald rightly pointed out in their report. So careful use of capital is of paramount importance.